Clinical-stage biotechnology company Synthekine has appointed Susan M. Molineaux, Ph.D. as its new Chief Executive Officer, marking a leadership transition as the company advances...
Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora, Ph.D. will be its...